Indwara yo kudakora neza kw'imibonano mpuzabitsina, cyangwa icyo twita mu buvuzi ikibazo cyo kudakora neza kw'imibonano mpuzabitsina (ED) , ni ikibazo cy'ubuzima abantu benshi badashaka kuvugaho, ariko ni ikibazo gikunze kugaragara muri sosiyete. Ushobora kuba warumvise ibinini nk'igisubizo kuri ibi. Ariko ibyo binini bishobora kudakora kuri buri wese, cyangwa bigatera ingaruka mbi. Uyu munsi tugiye kuvuga ku ntambwe ikurikiraho abaganga basaba muri ibyo bihe. Iyo ni Alprostadil .
Alprostadil ni iki?
Muri make, uyu ni ubwoko bw'umuti wagura imiyoboro y'amaraso yacu kandi woroshya gutembera kw'amaraso (Vasodilator) . Uyu muti wongera amaraso ajya mu gitsina, bigatuma habaho kandi gukomeza guhagarara. Ikintu cyihariye ni uko Alprostadil isa n'ikintu gikorerwa mu mubiri wacu kandi kigafasha imiyoboro y'amaraso kuguma ifunguye.
Ariko ibi ni ingenzi cyane. Niba udafite ikibazo cyo kugabanya ingano y'ubugimbi (ED) , ntugomba gukoresha uyu muti. Nanone, gukoresha ibirenze urugero rwatanzwe na muganga bishobora kwangiza igitsina cyawe burundu ndetse no kutazongera kugikoresha.
Ese Alprostadil ikwiriye kuri njye? Ibyo wabwira muganga wawe
Niba imiti ikoreshwa mu kuvura indwara ya ED idakora neza kuri wewe cyangwa ikagutera ingaruka mbi, muganga wawe ashobora gufata Alprostadil nk'intambwe ikurikiraho yo kuvura.
Mbere yo gukoresha uyu muti, banza umenyeshe muganga wawe ibi bikurikira:
- Niba warigeze kugira ikibazo cyo kugira ubwivumbure kuri Alprostadil mu bihe byashize.
- Niba ufite allergie ku bindi biribwa, imiti, imiti irinda ubushyuhe, cyangwa irangi.
- Ku bijyanye n'imiti iyo ari yo yose ufata (harimo na muganga wanditse, ugurishwa ku giciro cya muganga (OTC), imiti y'ibimera, cyangwa vitamine).
- Niba warigeze kugira ubwoko ubwo aribwo bwose bwa implant y'igitsina.
- Niba wigeze kugira ikibazo cyo gushyukwa amasaha menshi mbere (priapism).
- Niba ufite ikibazo cy’igitsina cyawe, igitsina kigoramye cyane mu gihe cyo gushyukwa (indwara ya Peyronie), ubwandu bw’igitsina, cyangwa indwara igira ingaruka ku miterere y’amaraso (urugero: leukemia, multiple myeloma, indwara ya sickle cell).
Ukoresha uyu muti ute?
Alprostadil iza mu buryo bubiri bw'ingenzi. Ni ngombwa kumenya ubwo buryo bubiri.
| Uburyo bwo kuvura | Ibisobanuro |
|---|---|
| Inshinge za Alprostadil (inshinge) | Iza ari ifu. Ivangwa n'amazi hanyuma igaterwa mu ruhande rw'igitsina hakoreshejwe urushinge ruto cyane. Hari igihe itangwa nk'uruvange n'indi miti (Bimix, Trimix). Ntugahangayike, muganga wawe azakwigisha uburyo bwo kubikora neza. Igipimo kiratandukanye kuri buri muntu, bityo bishobora gufata igihe kugira ngo ubone igipimo gikwiye. |
| Gushyiramo ikinini mu muyoboro w'amaraso (Transurethral Alprostadil) | Ibi bimeze nk'ikinini gito cyane (suppository). Bigomba gushyirwa mu muyoboro w'inkari. Hanyuma bigashonga imbere bigashyirwa mu mubiri. Ariko, ubushakashatsi bwerekana ko ubu buryo budakora neza nk'urushinge, kandi hari ibyago byinshi byo kubabara no kubyimba mu gitsina. |
Ese hari amavuta ya Alprostadil?
Alprostadil iboneka kandi nk'amavuta cyangwa gel. Igenewe gusigwa ku mutwe w'igitsina mbere yo gukora imibonano mpuzabitsina. Ariko, ubu buryo ntiburakemerwa cyangwa ngo bukoreshwe cyane mu bihugu byinshi, harimo na Sri Lanka. Kubwibyo, ntabwo ari amahitamo asanzwe.
Ibintu by'ingenzi ugomba kumenya mugihe ukoresha
- Ishobora gukoreshwa kangahe?
- Uburyo bwo gutera: Ntugakoreshe inshuro zirenze ebyiri cyangwa eshatu mu cyumweru. Nyuma yo gukoresha rimwe, tegereza nibura amasaha 24 mbere yo kongera gukoresha.
- Uburyo bwo gupima umuyoboro w'amaraso mu nzira y'umuyoboro w'amaraso: Ntukawukoreshe inshuro zirenze ebyiri mu masaha 24.
- Bifata igihe kingana iki kugira ngo bikoreshwe?
- Uburyo bwo gutera inshinge: Ishyaka rigomba kubaho mu minota 5 kugeza kuri 20.
- Uburyo bwo gusohora umuyoboro w'amaraso mu muyoboro w'amaraso: Butangira gukora mu minota 10.
- Bifata igihe kingana iki kugira ngo umuntu asubire kumererwa neza?
- Ubusanzwe gukanguka bifata hagati y'iminota 30 n'isaha. Nubwo gukanguka gukomeje nyuma yo kurangiza, bigomba kurangira mu isaha imwe.
Iyo ukeneye kubonana na muganga ako kanya
Niba ubonye kimwe muri ibi bikurikira, gana muganga wawe vuba bishoboka:
- Iyo igitsina cy'umugabo kibabaye cyane mu gihe cyo gushyukwa.
- Niba ukangutse amasaha arenga 2 .
- Niba ubyimbye cyangwa ubabara mu mabya, mu birenge, cyangwa mu nkengero zayo.
- Niba ugaragaje ibimenyetso by'indwara isa n'ibicurane nko kugira umuriro, ubukonje, isesemi no kuruka.
- Niba wumva umeze nk'ufite isereri cyangwa unaniwe.
- Niba hari inkovu cyangwa ibibyimba bikomeye ku gitsina cy'umugabo.
- Iyo urushinge rwacitse mu gihe cyo gutera urushinge.
Niba gushyukwa kwawe kumara amasaha arenga 4, ni ikibazo cyihutirwa. Jya mu cyumba cy’ubutabazi bw’ibanze cy’ibitaro biri hafi yawe (ETU). Iyo iki kibazo kidavuwe vuba, gishobora kwangiza burundu ingingo z’igitsina.
Umuburo w'ingenzi: Ntugakoreshe hamwe n'indi miti!
Iki ni cyo kintu cy'ingenzi ugomba kwibuka. Ntukagikoreshe mu buryo ubwo aribwo bwose hamwe n'indi miti yo kunywa ya ED nka Alprostadil cyangwa Viagra®.
Iyo ubikoze, uba ufite ibyago byinshi byo kugira ikibazo cyo guhagarara nabi mu gihe kirenze amasaha 4 (priapism), indwara ikomeye isaba kuvurirwa mu cyumba cy’ubutabazi bw’ibanze (ETU).
Ubutumwa bwo kujyana mu rugo
- Alprostadil ni umuti wa kabiri uvura ikibazo cyo guhagarara k'uburemba (ED), ukoreshwa iyo ibinini bidakora neza.
- Ibi biza ari urushinge cyangwa ikinini gishyirwa mu muyoboro w'inkari. Muganga wawe azaguhitiramo uburyo bukubereye kandi akwigishe uko bukoreshwa.
- Buri gihe kurikiza amabwiriza ya muganga wawe. Ntukigere ukoresha ibirenze urugero rw'umuti watanzwe n'inshuro wahawe.
- Indwara yo mu mutwe imara amasaha arenga 4 ni ikibazo cyihutirwa cy’ubuvuzi kandi bisaba koherezwa mu bitaro byihutirwa (ETU).
- Ntugakoreshe hamwe n'indi miti ya ED nka Alprostadil cyangwa Viagra® ku mpamvu iyo ari yo yose.
- Kudakora neza kw'intanga ngore ni indwara ikunze kugaragara mu buzima. Ntugatinye cyangwa ngo ugire isoni zo kubikora. Vugana na muganga wawe nta guhishanya maze uhitemo igisubizo cyizewe kandi cyiza kuri wewe.
💬 Comments (0)
No comments yet. Be the first to share your thoughts here.
Add Your Comment